Non-invasive Computer-Aided Phenotyping of Vasculopathy
Completed
Conditions studied: Carotid Atherosclerosis, Peripheral Arterial Disease
In brief
The investigators use MRI and/or CT to evaluate the extent, as well as, the structure, composition, and functional aspects of atherosclerotic plaques in human carotid and femoral arteries in patients scheduled to undergo an endarterectomy of the aforementioned vascular beds as part of their routine clinical care.
Key facts
- Study ID
- NCT02143102
- Run by
- Elucid Bioimaging Inc.
- People needed
- 125
- Starts
- 2014-07-01
- Expected to finish
- 2017-06-30
- Last updated by the study team
- 2018-08-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Individuals must meet one of the following inclusion criteria in order to be eligible to participate in the study:
- Case subjects will be patients with documented carotid atherosclerosis, scheduled for magnetic resonance or CT angiography and subsequent elective endarterectomy with 30 days of enrollment in the study
- Case subjects will be patients with peripheral arterial disease (PAD) with clinical symptoms, scheduled for magnetic resonance or CT angiography and indicated endarterectomy of diseased areas of femoral arteries within 30 days of enrollment in the study
You may not qualify if…
- Subjects with claustrophobia or inability to tolerate prior MRI studies.
- Subjects with metal implants that are not MRI compatible (LSU detailed checklist to be attached) including: Subjects with any type of bio-implant activated by mechanical, electronic, or magnetic means (e.g. cochlear implants, pacemakers, neurostimulators, biostimulators, electronic infusion pumps, etc.). Subjects with any type of ferromagnetic bio-implant that could potentially be displaced or damaged, such as aneurysm clips, metallic skull plates, etc.
- Subjects with a history of kidney disease or dialysis that are unable to receive intravenous gadolinium contrast material.
- Female subjects. A urine pregnancy test will be required of all female subjects of childbearing potential prior to inclusion in this study. Pregnant or nursing females will be excluded from the study.
- Subjects who cannot adhere to the experimental protocol.
- Subjects allergic to contrast material.
Where it is running
- West Jefferson Medical Center — Marrero, Louisiana, United States
- LSU ILH — New Orleans, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.